Evidence map›Paper›PMID 34144706›Full record

ArticleNutrition & metabolism2021

Estradiol regulates intestinal ABCG2 to promote urate excretion via the PI3K/Akt pathway.

Lei Liu, Tianyi Zhao, Lizhen Shan, Ling Cao, Xiaoxia Zhu, Yu Xue

Open access · goldAbstract read
In one paragraph

Article in Nutrition & metabolism, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 52 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Observational
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Lei Liu *Department of Rheumatology, The Second Affiliated Hospital of Zhejiang University, School of Medicine, Zhejiang, People's Republic of China, 310000.
Tianyi Zhao *Division of Rheumatology, Huashan Hospital, Fudan University, Shanghai, People's Republic of China, 200040.
Lizhen ShanDepartment of Endocrinology, The Second Affiliated Hospital of Zhejiang University, School of Medicine, Zhejiang, People's Republic of China, 310000.
Ling CaoDivision of Rheumatology, Huashan Hospital, Fudan University, Shanghai, People's Republic of China, 200040.
Xiaoxia ZhuDivision of Rheumatology, Huashan Hospital, Fudan University, Shanghai, People's Republic of China, 200040.
Yu XueDivision of Rheumatology, Huashan Hospital, Fudan University, Shanghai, People's Republic of China, 200040. yxue@unirheuma.org.
Fudan University · CNHuashan Hospital · CNSecond Affiliated Hospital of Zhejiang University · CN

Funding

National Natural Science Foundation of China 81801597
6 · The paper itself

Abstract

objectivesThe study of sex differences in hyperuricemia can provide not only a theoretical basis for this clinical phenomenon but also new therapeutic targets for urate-lowering therapy. In the current study, we aimed to confirm that estradiol can promote intestinal ATP binding cassette subfamily G member 2 (ABCG2) expression to increase urate excretion through the PI3K/Akt pathway.

methodsThe estradiol levels of hyperuricemia/gout patients and healthy controls were compared, and a hyperuricemia mouse model was used to observe the urate-lowering effect of estradiol and the changes in ABCG2 expression in the kidney and intestine. In vivo and in vitro intestinal urate transport models were established to verify the urate transport function regulated by estradiol. The molecular pathway by which estradiol regulates ABCG2 expression in intestinal cells was explored.

resultsThe estradiol level of hyperuricemia/gout patients was significantly lower than that of healthy controls. Administering estradiol benzoate (EB) to both male hyperuricemic mice and female mice after removing the ovaries confirmed the urate-lowering effect of estradiol, and hyperuricemia and estradiol upregulated the expression of intestinal ABCG2. Estradiol has been confirmed to promote urate transport by upregulating ABCG2 expression in intestinal urate excretion models in vivo and in vitro. Estradiol regulates the expression of intestinal ABCG2 through the PI3K/Akt pathway.

conclusionOur study revealed that estradiol regulates intestinal ABCG2 through the PI3K/Akt pathway to promote urate excretion, thereby reducing serum urate levels.

Indexed as

ABCG2EstradiolHyperuricemiaIntestinePI3K/Akt

Identifiers

PMID34144706
PMCPMC8212495
OpenAlexW3169977675

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.